Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA360597
Max Phase: Preclinical
Molecular Formula: C23H30N4O3
Molecular Weight: 410.52
Molecule Type: Small molecule
Associated Items:
ID: ALA360597
Max Phase: Preclinical
Molecular Formula: C23H30N4O3
Molecular Weight: 410.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CO/N=C/c1cc(C)c(OCCCCCN2CCN(c3ccncc3)C2=O)c(C)c1
Standard InChI: InChI=1S/C23H30N4O3/c1-18-15-20(17-25-29-3)16-19(2)22(18)30-14-6-4-5-11-26-12-13-27(23(26)28)21-7-9-24-10-8-21/h7-10,15-17H,4-6,11-14H2,1-3H3/b25-17+
Standard InChI Key: QQEKXHKBBAKKNT-KOEQRZSOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 410.52 | Molecular Weight (Monoisotopic): 410.2318 | AlogP: 4.17 | #Rotatable Bonds: 10 |
Polar Surface Area: 67.26 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.59 | CX LogP: 3.59 | CX LogD: 3.59 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.33 | Np Likeness Score: -1.29 |
1. Chern JH, Lee CC, Chang CS, Lee YC, Tai CL, Lin YT, Shia KS, Lee CY, Shih SR.. (2004) Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones., 14 (20): [PMID:15380197] [10.1016/j.bmcl.2004.07.084] |
Source(1):